fenoldopam has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous fenoldopam, a selective dopamine-1 receptor agonist, was compared with placebo in this randomized, double-blind, two-period crossover study to evaluate its effects on intraocular pressure, aqueous dynamics, and macular blood flow in patients with elevated intraocular pressure or primary open-angle glaucoma." | 9.08 | Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension. ( Audet, P; Boike, SC; Everitt, DE; Jorkasky, D; Piltz-Seymour, JR; VanCoevorden, R; Zariffa, N, 1997) |
| "Intravenous fenoldopam, a selective dopamine-1 receptor agonist, was compared with placebo in this randomized, double-blind, two-period crossover study to evaluate its effects on intraocular pressure, aqueous dynamics, and macular blood flow in patients with elevated intraocular pressure or primary open-angle glaucoma." | 5.08 | Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension. ( Audet, P; Boike, SC; Everitt, DE; Jorkasky, D; Piltz-Seymour, JR; VanCoevorden, R; Zariffa, N, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Everitt, DE | 1 |
| Boike, SC | 1 |
| Piltz-Seymour, JR | 1 |
| VanCoevorden, R | 1 |
| Audet, P | 1 |
| Zariffa, N | 1 |
| Jorkasky, D | 1 |
1 trial available for fenoldopam and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension.
Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Fenoldopam; Glaucoma, Open-Angle; Head | 1997 |